MN
Minerva Neurosciences Inc
🇩🇪XFRA.4MNAGermanyHealthcare
€3.10EURdown -0.41 (-11.68%)After-hoursEnd of day8:12 PM
Price€3.10-0.41 (-11.68%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US6033802058
- CUSIP
- Not reported
Company
- Employees
- 7
- Headquarters
- Burlington, United States
- CEO
- Dr. Remy Luthringer Ph.D.
Market
- Shares outstanding
- 47.7M
- Market cap
- €148.02M
Highlights
- Market cap
- €148.02M
- EPS LTM
- -$4.99
- P/E LTM
- -1.13
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$394.35M-3,611.7%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$18.78B-112,163.14%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.